Latest news
AbbVie: Strong Q2 And New Catalysts Keep Me Bullish (NYSE:ABBV) - Seeking AlphaSeeking Alpha · Mon, 03 Aug 2026 14:05:31 GMTHold AbbVie Post-Earnings, Sell This Health Care Stock Soon (NYSE:ABBV) - Seeking AlphaSeeking Alpha · Fri, 31 Jul 2026 12:15:53 GMTAbbVie stock falls despite Q2 2026 beat (ABBV:NYSE) - Seeking AlphaSeeking Alpha · Fri, 31 Jul 2026 07:00:00 GMTAbbVie Earnings Preview: Immunology portfolio remains in focus amid Humira decline - Seeking AlphaSeeking Alpha · Thu, 30 Jul 2026 07:00:00 GMTAbbVie wins EU clearance for Rinvoq as first systemic treatment for non-segmental vitiligo (ABBV:NYSE) - Seeking AlphaSeeking Alpha · Wed, 29 Jul 2026 07:00:00 GMT